Home | Welcome to Contract Pharma   
Last Updated Monday, May 20 2013
Print

Financial Reports

Related Searches:

Filter by:

February 4, 2010
Vaccine sales were up 85% to $2.4 billion with flu pre-pandemic sales accounting for $1.3 billion in the quarter.   Read More »
February 4, 2010
Specialty pharmaceuticals sales were up 18% to $995 million in the quarter, and for the year sales were up 5% to $3.7 billion.   Read More »
February 4, 2010
Growth in the quarter was driven by an increase in Specialty Injectable Pharmaceuticals, with sales in the Americas up 27% to $439.2 million, in Europe, Middle East & Africa, sales were $76.7 million (+21%), and in the Asia Pacific region, sales were   Read More »
February 3, 2010
Pfizer completed its acquisition of Wyeth in the quarter. U.S. revenues were $7.4 billion in the quarter (+42%).   Read More »
February 3, 2010
The company achieved record sales for the year.   Read More »
January 28, 2010
Focused BMS posts revenue bump   Read More »
January 28, 2010
Job cuts at AZ, with a rough 5-year stretch ahead   Read More »
January 28, 2010
ImClone acquisition costs in the rear-view mirror, earnings returned to form   Read More »
January 28, 2010
Early-Stage down, Late-Stage up   Read More »
January 28, 2010
Late-stage programs increase R&D costs   Read More »
January 28, 2010
Record revenues for Celgene in 2009   Read More »
January 27, 2010
Worldwide pharmaceutical sales were up 5% to $4.8 billion in the quarter.   Read More »
January 27, 2010
In the quarter, Pharmaceutical sales were up 21% to $7.8 billion.   Read More »
January 27, 2010
Product sales increased 30% to a record $1.8 billion in 4Q09.   Read More »
January 26, 2010
Worldwide Pharmaceutical sales were $22.5 billion for the year (-8%), while Worldwide Medical Devices and Diagnostics sales were $23.6 billion for year (+2%).   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On